Bioventus (Nasdaq:BVS) announced today that it received FDA 510(k) clearance for both its TalisMann and StimTrial offerings.

Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced today a significant milestone with the U.S. Food and Drug Administration (FDA) 510(k) clearances for both ...

There are no significant differences in pain relief, opioid reduction, and adverse events between TTP and DTP approaches to PNS implantation.

Contacts Nalu Medical, Inc. Jon Ruais [email protected] 760-448-2360 ...

The SPRINT PNS System is indicated for up to 60 days for: Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; symptomatic relief of post-traumatic pain; ...

CARLSBAD, Calif.-- (BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.

Published results showed percutaneous peripheral nerve stimulation may provide clinically meaningful and statistically significant reductions in pain, disability and pain interference in patients ...

1. Hatheway J, Ratino T, Swain AR, et al. Long-Term Pain Relief Delivered by Micro-Implantable Pulse Generator: Findings from a Large-Scale, Real-World Data Peripheral Nerve Stimulation Patient ...

MossRehab is the first in the region to use the SPRINT endura Peripheral Nerve Stimulation (PNS) System, a promising new therapy for acute and chronic pain. By Queen Muse · 11/20/2019, 11:46 a.m.